Global Urology Devices Market to grow at a CAGR of 7.77% to reach USD 63,320.19 million by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The global urology devices market is expanding due to the increasing incidence of kidney stones, urinary incontinence, benign prostatic hyperplasia (BPH), and prostate and bladder cancers, particularly among the elderly population. Advancements in minimally invasive and robotic-assisted surgical techniques, along with improved diagnostic technologies, are accelerating their adoption. Furthermore, rising healthcare expenditures, the expansion of healthcare infrastructure in emerging economies, and the growing prevalence of lifestyle-related risk factors such as obesity and diabetes are further contributing to the increasing demand for urology devices.

DelveInsight's "Urology Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Urology Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Urology Devices market, get a snapshot of the report Urology Devices Market Trends
https://www.delveinsight.com/sample-request/urology-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Urology Devices Overview
Urology devices are medical instruments and equipment used for the diagnosis, treatment, and management of disorders affecting the urinary tract and male reproductive system. These devices help healthcare professionals treat conditions related to the kidneys, bladder, ureters, urethra, and prostate.
They include a wide range of products such as endoscopes, lithotripters (used for breaking kidney stones), catheters, dialysis devices, laser systems, and robotic-assisted surgical tools. Urology devices are commonly used to manage conditions like kidney stones, urinary incontinence, benign prostatic hyperplasia (BPH), urinary tract infections, and urological cancers.
With advancements in minimally invasive and robotic-assisted technologies, modern urology devices are improving treatment precision, reducing recovery time, and enhancing patient outcomes.

DelveInsight Analysis: The global urology devices market size is projected to grow substantially, rising from USD 34,898.97 million in 2024 to USD 63,320.19 million by 2032, registering a CAGR of 7.77% during the 2025-2032 forecast period, indicating strong and sustained market expansion.

Urology Devices Market Insights
Geographically, North America is expected to hold the leading position in the global urology devices market in 2024, representing nearly 38% of the overall market share. This dominance is largely attributed to the significant disease burden, well-established healthcare infrastructure, and rapid adoption of advanced medical technologies in the region. The United States plays a key role due to its large patient population, with more than 37 million individuals affected by chronic kidney disease (CKD) and over 810,000 people living with end-stage renal disease (ESRD). Among these patients, around 70% rely on dialysis while about 30% have undergone kidney transplantation, driving consistent demand for dialysis devices and related consumables.

To read more about the latest highlights related to Urology Devices, get a snapshot of the key highlights entailed in the Urology Devices Market Insights
https://www.delveinsight.com/report-store/urology-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Urology Devices Market Report
• In September 2025, Johnson & Johnson received U.S. FDA approval for INLEXZOTM, a groundbreaking gemcitabine intravesical system for treating Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer. This is the first and only intravesical drug-releasing system for this condition.
• In June 2025, Boston Scientific's Rezūm Water Vapor Thermal Therapy received FDA clearance for a label expansion, allowing treatment of BPH in larger prostate volumes up to 150 g, broadening the eligible patient population for this minimally invasive therapy.
• In April 2025, Bright Uro's Glean Urodynamics System received FDA 510(k) clearance. The wireless ambulatory urodynamics system is catheter-free, offering improved patient comfort and more physiologically accurate measurement of lower urinary tract function.
• In April 2024, Olympus launched the RenaFlexTM single-use flexible ureteroscope, cleared by the FDA, providing both diagnostic and therapeutic access for kidney, ureter, and bladder procedures, reducing infection risk and eliminating reprocessing requirements.
• In April 2024, Dornier MedTech introduced UroGPTTM, an AI-powered digital assistant for kidney stone patients, helping improve understanding, decision-making, and reducing unnecessary clinic visits.
• In February 2024, Calyxo launched the 2nd-generation CVAC System, FDA-cleared for aspiration-based stone removal via ureteroscopy, with enhanced features including micro-jet irrigation and a larger outflow lumen.
• In May 2024, Dexcom received FDA clearance for its Stelo CGM System. Similar to Abbott's product, the Stelo is a prescription-free CGM aimed at non-insulin-dependent adults with diabetes, broadening the market for continuous glucose monitoring.
• In May 2024, Huawei received CE Mark certification in the European Union for its Huawei Watch D. The device is cleared as a medical device for blood pressure monitoring and ECG analysis, marking a significant step for the Chinese tech giant in expanding its health-focused wearable products in the European market.
• In January 2024, Boston Scientific Corporation agreed to acquire Axonics, Inc., a medical technology company focused on sacral neuromodulation for bladder and bowel dysfunction. This acquisition aims to significantly expand Boston Scientific's urology portfolio.
• Thus, owing to such developments in the market, rapid growth will be observed in the Urology Devices market during the forecast period

Key Players in the Urology Devices Market
Some of the key market players operating in the Urology Devices market include- Medtronic plc, Boston Scientific Corporation, Fresenius Medical Care AG, Becton, Dickinson and Company (BD), Olympus Corporation, Karl Storz SE & Co. KG, B. Braun SE, Coloplast A/S, Baxter, Cook Medical, Intuitive Surgical, Inc., Stryker Corporation, Teleflex Incorporated, Siemens Healthineers, Richard Wolf GmbH, Dornier MedTech, Laborie Medical Technologies, Convatec Inc., Cardinal Health, NIPRO Corporation, and others.

Which MedTech key players in the Urology Devices market are set to emerge as the trendsetter explore @ Key Urology Devices Companies
https://www.delveinsight.com/sample-request/urology-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Urology Devices Market Landscape
The global urology devices market is expanding due to several important factors, particularly the increasing prevalence of urological conditions such as kidney stones, urinary incontinence, benign prostatic hyperplasia (BPH), and cancers of the prostate and bladder. The growing aging population also contributes significantly to market demand, as older individuals are more susceptible to these disorders. In addition, technological advancements, especially minimally invasive and robotic-assisted surgical procedures, are improving treatment outcomes and encouraging wider adoption among healthcare providers. Greater awareness and earlier diagnosis through advanced imaging and diagnostic technologies are further supporting market growth. Moreover, rising healthcare spending, supportive reimbursement policies in developed regions, and improving healthcare infrastructure in emerging markets are driving increased adoption of urology devices.

Scope of the Urology Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Urology Devices Market Segmentation By Product Type: (Instruments {Endoscopic Devices [Cystoscopes, Ureteroscopes, Nephroscopes, Resectoscopes, and Laparoscopes], Dialysis Devices [Hemodialysis Devices, Peritoneal Dialysis Devices], Laser and Lithotripsy Devices, Robotic Surgical Systems, Urodynamic Systems, and Others}, Consumables & Accessories {Dialysis Consumables, Urology Catheters & Guidewires, Implants & Stents, Urinary Drainage Bags, and others
• Urology Devices Market Segmentation By Application: Urinary Stones (Urolithiasis), Benign Prostatic Hyperplasia (BPH), Kidney Diseases, Urological Cancer, Urinary Incontinence, and others
• Urology Devices Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers (ASC), Dialysis Centers, Homecare Settings, and others
• Urology Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Urology Devices Companies: Medtronic plc, Boston Scientific Corporation, Fresenius Medical Care AG, Becton, Dickinson and Company (BD), Olympus Corporation, Karl Storz SE & Co. KG, B. Braun SE, Coloplast A/S, Baxter, Cook Medical, Intuitive Surgical, Inc., Stryker Corporation, Teleflex Incorporated, Siemens Healthineers, Richard Wolf GmbH, Dornier MedTech, Laborie Medical Technologies, Convatec Inc., Cardinal Health, NIPRO Corporation, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.